Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Psychopharmacology (Berl). 2008 Jun 30;202(1-3):329–341. doi: 10.1007/s00213-008-1224-6

Figure 2.

Figure 2

Effects of PCPA pretreatment (4 × 200 mg/kg/day) on performance of rats on the AST (n = 9–11 per group). PCPA-treated rats required significantly more trials to reach criterion on the R1 reversal task compared to vehicle-treated controls (*p < 0.001 compared to control rats on the same stage; +p < 0.001 compared to other tasks for the same group).